ReviewImmunoTargets and therapy2014

Antigen-based immunotherapy for the treatment of acute lymphoblastic leukemia: the emerging role of blinatumomab.

Mark R LitzowPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.